INIS
ablation
5%
accuracy
13%
algorithms
6%
animals
5%
anticoagulants
100%
applications
7%
assessments
27%
balances
5%
coagulants
9%
comparative evaluations
14%
concentration
52%
control
8%
corrections
5%
correlations
8%
data
14%
detection
6%
dimers
5%
drugs
24%
emergencies
10%
extraction
5%
guidelines
5%
hematology
5%
hemophilia
5%
hemostatics
7%
heparin
25%
high-performance liquid chromatography
9%
humans
17%
implementation
11%
in vitro
12%
in vivo
6%
information
14%
interactions
12%
interleukins
5%
laboratories
24%
levels
32%
lupus
6%
mass spectrometry
19%
metabolites
11%
molecular weight
10%
monitoring
8%
patients
61%
peaks
10%
performance
16%
plasma
60%
proteins
5%
range
16%
reagents
7%
recommendations
11%
reviews
25%
risks
13%
sensitivity
16%
specificity
7%
stability
6%
standardization
7%
testing
16%
thrombin
53%
thromboplastin
6%
thrombosis
6%
urine
14%
validation
13%
values
13%
venoms
7%
Pharmacology, Toxicology and Pharmaceutical Science
Andexanet Alfa
6%
Anticoagulant Agent
13%
Apixaban
9%
Betrixaban
13%
Blood Clotting Factor 10a Inhibitor
18%
Blood Stasis
7%
Dabigatran
8%
Dextran Sulfate
5%
Direct Oral Anticoagulant
38%
Haemophilia A
5%
Heparin
8%
Low Molecular Weight Heparin
6%
Recombinant Interleukin 2
5%
Rivaroxaban
15%
Therapeutic Drug Monitoring
5%
Thrombin
20%
Thrombin Inhibitor
8%
Thrombosis
5%
Venous Thromboembolism
6%
Keyphrases
Analytical Samples
5%
Andexanet Alfa
5%
Anticoagulant Effect
5%
Atrial Fibrillation Ablation
5%
Clotting Test
5%
Common Data Elements
5%
Diagnostic Test Accuracy
5%
Direct Oral Anticoagulants
5%
Hokusai
5%
In Vitro Study
5%
In Vivo Animal Studies
5%
Mass Spectrometry
5%
Measurement Analysis
5%
Multicenter Trial
5%
Performance Stability
5%
Peri-procedural
5%
Pharmacologically Active
5%
Potential Drug Interactions
5%
R2 Score
5%
Recombinant interleukin-2
5%
Rivaroxaban
5%
ST Genesia
5%
Strip Test
5%
Therapeutic Drug Monitoring
5%
Time to Peak
5%